Controversies in COPD

European Respiratory Society Monograph, Vol. 69. 2015
ISBN (electronic): 9781849840644
DOI: 10.1183/2312508X.erm6915

COPD is one of the most common diseases worldwide and is projected to be the third leading cause of death by 2020. But that does not mean it is easy to understand or manage. In everyday practice, pulmonologists face areas of controversy in COPD, for which evidence-based medicine is often unavailable. This ERS Monograph considers where the current controversies in COPD lie, discussing areas such as screening, premature birth, asthma–COPD overlap syndrome, treatment, rehabilitation and palliative care. This book will be of great interest to both clinicians and scientists, and aims to stimulate further discussion about this diverse and fascinating disease.

CME tests: ERS Monograph 69 - Controversies in COPD - Test 1
CME tests: ERS Monograph 69 - Controversies in COPD - Test 2
CME tests: ERS Monograph 69 - Controversies in COPD - Test 3
CME tests: ERS Monograph 69 - Controversies in COPD - Test 4
CME tests: ERS Monograph 69 - Controversies in COPD - Test 5
Preface Tobias Welte, Robert Bals Eur Respir Monogr 2015; 69: vii-viii
Guest Editors Eur Respir Monogr 2015; 69: ix-x
Introduction Antonio Anzueto, Yvonne Heijdra, John R. Hurst Eur Respir Monogr 2015; 69: xi
List of abbreviations Eur Respir Monogr 2015; 69: xiii
Screening and case finding Joan B. Soriano, David Price Eur Respir Monogr 2015; 69: 1-25
COPD as a consequence of premature birth? Charlotte E. Bolton Eur Respir Monogr 2015; 69: 26-34
Nonsmokers and biomass exposure Alejandra Ramírez-Venegas, Raul H. Sansores, Mónica Velázquez-Uncal, Oliver Pérez-Bautista Eur Respir Monogr 2015; 69: 35-46
a₁-antitrypsin deficiency Damian Bruce-Hickman, Catherine M. Greene, Bibek Gooptu Eur Respir Monogr 2015; 69: 47-84
The asthma–COPD overlap syndrome Miriam Barrecheguren, Cristina Esquinas, Marc Miravitlles Eur Respir Monogr 2015; 69: 85-95
The overlap with bronchiectasis Miguel Ángel Martínez-García, Luis Máiz Carro, David de la Rosa Carrillo Eur Respir Monogr 2015; 69: 96-108
Coexistent COPD and ILD Matthew D. Jankowich, Sharon Rounds Eur Respir Monogr 2015; 69: 109-120
The value of CT scanning Samuel Y. Ash, George R. Washko Eur Respir Monogr 2015; 69: 121-133
Re-assessing the importance of FEV₁ decline Jørgen Vestbo, Peter Lange Eur Respir Monogr 2015; 69: 134-142
The use of multidimensional indices Bartolome R. Celli, Ciro Casanova Macario Eur Respir Monogr 2015; 69: 143-160
What is bacterial colonisation in COPD? Arjun Mohan, Sanjay Sethi Eur Respir Monogr 2015; 69: 161-171
Non-tuberculous mycobacterial lung disease and COPD Chun-Ta Huang, Meng-Rui Lee, Chin-Chung Shu, Jann-Yuan Wang, Pan-Chyr Yang Eur Respir Monogr 2015; 69: 172-184
Pneumonia or exacerbation of COPD? Diego Jose Maselli, Marcos I. Restrepo Eur Respir Monogr 2015; 69: 185-196
Prophylactic antibiotics David J. Serisier Eur Respir Monogr 2015; 69: 197-212
Inhaled medication: which device for which patient? Mario Cazzola, Paola Rogliani Eur Respir Monogr 2015; 69: 213-223
The importance of physical activity Daniel Langer, Heleen Demeyer, Thierry Troosters, Rik Gosselink Eur Respir Monogr 2015; 69: 224-239
How to assess the benefits of pulmonary rehabilitation Carlos Augusto Camillo, Christian Osadnik, Wim Janssens, Thierry Troosters Eur Respir Monogr 2015; 69: 240-255
Measurable aspects of health status in clinical practice Jan H. Vercoulen, A. Rogier Donders, Jeannette B. Peters Eur Respir Monogr 2015; 69: 256-268
The role of telemedicine Annemarie L. Lee, Roger S. Goldstein Eur Respir Monogr 2015; 69: 269-296
The challenge of palliative care Laura-Jane Smith, Jennifer K. Quint Eur Respir Monogr 2015; 69: 297-322